|
INVO Invo Bioscience Inc 1417926 |
| Income Statement |
|
Revenue
|
form10-q
|
1,433,151 |
|
Net Income
|
form10-q
|
-1,630,662 |
|
Profit Margin
|
|
-113.78% |
| Balance Sheet |
|
Current Assets
|
1,957,481 |
|
Assets
|
17,019,489 |
|
Current Liabilities
|
8,655,458 |
|
Liabilities
|
17,042,805 |
|
Equity
|
-23,316 |
|
Shares Out
|
3,906,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,357,021 |
|
Investing Cash Flow
|
-29,239 |
| Market Analysis |
Market Cap
|
2,745,419 |
|
PB
|
160.00 |
|
EPS
|
-3.24 |
|
PS
|
0.48 |
|
FCF
|
-2,386,260 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INVO documents filed with the SEC.
INVO Filings
Clear
